Online First Articles

ISSN: 0344-5704 (Print) 1432-0843 (Online)

Articles not assigned to an issue (46 articles)

previous Page of 3

  1. No Access

    Letter to the Editor

    Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not)

    Salvatore Maria Corsello, Roberto Salvatori…
    Get Access

  2. No Access

    Original Article

    Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration–effect relationship support clinical dose and regimen selection

    Hong Xiang, Arthur E. Reyes II, Steve Eppler…
    Look Inside Get Access

  3. No Access

    Original Article

    Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

    David Tougeron, Ulrich Cortes, Aurélie Ferru…
    Look Inside Get Access

  4. Original Article

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study

    Edward M. Wolin, Ke Hu, Gareth Hughes…
    Download PDF (420KB) View Article

  5. No Access

    Original Article

    A phase I, open-label, mass balance study of [14C] dacomitinib (PF-00299804) in healthy male volunteers

    Carlo L. Bello, Evan Smith, Ana Ruiz-Garcia…
    Look Inside Get Access

  6. No Access

    Short Communication

    DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity

    Enrica Rumiato, Elisa Boldrin, Alberto Amadori…
    Look Inside Get Access

  7. Original Article

    Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments

    Jennifer L. Pauley, John C. Panetta…
    Download PDF (410KB) View Article

  8. No Access

    Original Article

    Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study

    R. P. Jones, P. Sutton, R. M. D. Greensmith…
    Look Inside Get Access

  9. No Access

    Original Article

    The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis

    Nimita Dave, Gary A. Gudelsky, Pankaj B. Desai
    Look Inside Get Access

  10. Original Article

    Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib

    Peng He, Gang Li
    Download PDF (649KB) View Article

  11. No Access

    Letter to the Editor

    Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view

    Maria Isabel Mas-Fuster, Amelia Ramon-Lopez…
    Get Access

  12. No Access

    Original Article

    Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines

    Linda Sooman, Simon Ekman, Claes Andersson…
    Look Inside Get Access

  13. No Access

    Original Article

    Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

    Pei-Jian Peng, Xue-Qing Ou, Zhi-Bin Chen, Hai Liao…
    Look Inside Get Access

  14. No Access

    Original Article

    Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer

    Katsushi Takebayashi, Eiji Mekata, Hiromichi Sonoda…
    Look Inside Get Access

  15. No Access

    Original Article

    Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies

    T. H. Han, R. Chen, R. Advani, R. B. Berryman…
    Look Inside Get Access

  16. No Access

    Original Article

    The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases

    Anthony El-Khoueiry, James A. Posey…
    Look Inside Get Access

  17. No Access

    Original Article

    Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinoma

    Peter L. Bonate, A. Benjamin Suttle
    Look Inside Get Access

  18. No Access

    Original Article

    Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells

    Min Shi, Bingxiang Lou, Jun Ji, Hailong Shi…
    Look Inside Get Access

  19. No Access

    Original Article

    A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors

    Syma Iqbal, Heinz-Josef Lenz, David R. Gandara…
    Look Inside Get Access

  20. No Access

    Original Article

    Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy

    Cui Chen, Fenghua Wang, Zhiqiang Wang, Cong Li…
    Look Inside Get Access
previous Page of 3